Literature DB >> 9627596

Diagnosis and management of stenotic aorto-arteriopathy in childhood.

S J D'Souza1, W S Tsai, M M Silver, P Chait, L N Benson, E Silverman, D Hebért, J W Balfe.   

Abstract

Stenotic aorto-arteriopathy is an uncommon vascular lesion characterized by segmental arterial stenoses. We reviewed the experience with several management algorithms to define the most effective management course. The clinical records of 14 pediatric patients with acquired SAA who presented over a 16-year period were reviewed. Most patients presented with a mid-thoracoabdominal coarctation and were diagnosed with Takayasu arteritis. Differentiating between Takayasu arteritis and fibromuscular dysplasia was difficult on clinical grounds or by angiography. Medical management of the end-organ disease and renovascular hypertension was only palliative. Selective percutaneous transluminal balloon angioplasty of the stenotic renal arteries had only transient benefits; renal autotransplantation had slightly better success. Dilation of stenosed aortic segments with balloon-expandable endovascular stents and subsequent renal autotransplantation proved useful. Distinguishing SAA resulting from fibromuscular dysplasia caused by Takayasu arteritis in the chronic vaso-occlusive phase may be unnecessary for effective treatment. Therapy should focus on interventions to minimize the end-organ damage caused by the vaso-occlusive manifestations of the disorders.

Entities:  

Mesh:

Year:  1998        PMID: 9627596     DOI: 10.1016/s0022-3476(98)70401-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  16 in total

Review 1.  Renovascular hypertension--is it fibromuscular dysplasia or Takayasu arteritis.

Authors:  Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2012-03-28       Impact factor: 3.714

Review 2.  A review of vascular surgery in the pediatric population.

Authors:  Shawn D St Peter; Daniel J Ostlie
Journal:  Pediatr Surg Int       Date:  2006-09-27       Impact factor: 1.827

Review 3.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

4.  Coarctation of the aorta diagnosed by physical examination after imaging: two case reports.

Authors:  B Kaya; A Deniz; S Paydas; E Aksungur; M Balal; O Akkus; M Demirtas
Journal:  Herz       Date:  2012-12-23       Impact factor: 1.443

5.  Aortic stent and renal autotransplantation for the management of renovascular hypertension with Takayasu's arteritis: report of a case.

Authors:  Hyung-Kee Kim; Jong-Min Lee; Min Hyun Cho; Seung Huh
Journal:  Surg Today       Date:  2013-03-20       Impact factor: 2.549

6.  A case of type A aortic dissection with underlying fibromuscular dysplasia.

Authors:  Viesha Ciura; Amy Bromley; Jason Wong
Journal:  J Radiol Case Rep       Date:  2011-10-01

7.  Mid-aortic syndrome: long-term outcome of 36 children.

Authors:  Albina Tummolo; Stephen D Marks; Marike Stadermann; Derek J Roebuck; Clare A McLaren; George Hamilton; Michael J Dillon; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

8.  Midaortic syndrome: 30 years of experience with medical, endovascular and surgical management.

Authors:  Diego Porras; Deborah R Stein; Michael A Ferguson; Gulraiz Chaudry; Ahmad Alomari; Khashayar Vakili; Steven J Fishman; James E Lock; Heung B Kim
Journal:  Pediatr Nephrol       Date:  2013-06-18       Impact factor: 3.714

9.  Mid-aortic syndrome in a 3-year-old girl successfully treated by aorto-aortic grafting and renal artery implantation into the graft.

Authors:  Tanja Kersnik Levart; Tomislav Klokocovnik
Journal:  Tex Heart Inst J       Date:  2012

10.  Differences between the pediatric and adult presentation of fibromuscular dysplasia: results from the US Registry.

Authors:  Rebecca Green; Xiaokui Gu; Eva Kline-Rogers; James Froehlich; Pamela Mace; Bruce Gray; Barry Katzen; Jeffrey Olin; Heather L Gornik; Ann Marie Cahill; Kevin E Meyers
Journal:  Pediatr Nephrol       Date:  2015-11-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.